Viewing Study NCT01016769


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2025-12-26 @ 5:03 PM
Study NCT ID: NCT01016769
Status: COMPLETED
Last Update Posted: 2019-06-26
First Post: 2009-11-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: